Back to search

Relation between tumour response to first-line chemotherapy and survival in advanced colorectal cancer: a meta-analysis

Data up to Jan 2025

Published2000
Citations422
References28

Total Citations Per Year

Abstract

References (28)

A Predictive Model for Aggressive Non-Hodgkin's Lymphoma

1993 • 4,650 citations

A predictive model for aggressive non-Hodgkin's lymphoma

1993 • 3,483 citations

Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. Advanced Colorectal Cancer Meta-Analysis Project.

1992 • 1,198 citations

Efficacy of adjuvant fluorouracil and folinic acid in colon cancer

1995 • 1,043 citations

Analysis of survival by tumor response.

1983 • 1,021 citations

Analysis of survival by tumor response.

1986 • 1,018 citations

Efficacy of intravenous continuous infusion of fluorouracil compared with bolus administration in advanced colorectal cancer. Meta-analysis Group In Cancer.

1998 • 979 citations

The benefit of leucovorin-modulated fluorouracil as postoperative adjuvant therapy for primary colon cancer: results from National Surgical Adjuvant Breast and Bowel Project protocol C-03.

1993 • 683 citations

Statistical validation of intermediate endpoints for chronic diseases

1992 • 629 citations

Controlled trial of fluorouracil and low-dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancer.

1997 • 582 citations

The validation of surrogate endpoints in meta-analyses of randomized experiments

2000 • 545 citations

ESTIMATING THE PROPORTION OF TREATMENT EFFECT EXPLAINED BY A SURROGATE MARKER

1997 • 483 citations

Prolonged Survival in Chronic Myelogenous Leukemia after Cytogenetic Response to Interferon-α Therapy

1995 • 446 citations

Reappraisal of Hepatic Arterial Infusion in the Treatment of Nonresectable Liver Metastases From Colorectal Cancer

1996 • 440 citations

Criteria for the Validation of Surrogate Endpoints in Randomized Experiments

1998 • 416 citations

Treatment of Non-Hodgkin's Lymphoma

1993 • 387 citations

Food and Drug Administration requirements for approval of new anticancer drugs.

1985 • 237 citations

Validation of Surrogate end Points in Multiple Randomized Clinical Trials with Failure Time end Points

2001 • 199 citations

Meta-analysis of randomized trials testing the biochemical modulation of fluorouracil by methotrexate in metastatic colorectal cancer

1994 • 193 citations

Meta-analysis of randomized trials testing the biochemical modulation of fluorouracil by methotrexate in metastatic colorectal cancer. Advanced Colorectal Cancer Meta-Analysis Project.

1994 • 188 citations

Surrogate and auxiliary endpoints in clinical trials, with potential applications in cancer and aids research

1994 • 167 citations

ON THE RELATIONSHIP BETWEEN RESPONSE TO TREATMENT AND SURVIVAL TIME

1996 • 130 citations

Statistical challenges in the evaluation of surrogate endpoints in randomized trials

2002 • 128 citations

Survival and response to chemotherapy for advanced colorectal adenocarcinoma. An eastern cooperative oncology group report

1980 • 117 citations

Comparing survival of responders and nonresponders after treatment: A potential source of confusion in interpreting cancer clinical trials

1983 • 76 citations

The relationship between an objective response to chemotherapy and survival in advanced colorectal cancer

1994 • 74 citations

Reporting Results From Chemotherapy Trials

1984 • 68 citations

Faster Access to Drugs for Serious or Life-Threatening Illnesses Through use of the Accelerated Approval Regulation in the United States

1998 • 13 citations

Cited By (0)

Loading...
Relation between tumour response to first-line chemotherapy and survival in advanced… (2000) – The Lancet | Metascience Observatory Explorer